CompaniesByCap
TSHA
Taysha Gene Therapies Inc. (TSHA)
NASDAQ · Healthcare

Taysha Gene Therapies Inc. Price to FCF Ratio 2020–2026

Price to free cash flow (P/FCF) ratio for Taysha Gene Therapies Inc. (TSHA): market cap divided by trailing twelve-month free cash flow. As of it is —.
From: 03/31/2024To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF

Taysha Gene Therapies Inc. Price to FCF Ratio — FAQ

Taysha Gene Therapies Inc. (TSHA) price to fcf ratio over the last 4 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TSHA's price to fcf ratio history?

The chart and table above show Taysha Gene Therapies Inc.'s price to fcf ratio by year and by quarter, including the growth rate.